GlaxoSmithKline Pharma reports 14% rise in Q2 net profit

GlaxoSmithKline Pharmaceuticals has reported unaudited results for the second quarter ended June 30, 2011.

The company’s net profit for the quarter ended June 30, 2011 rose by 14.38% at Rs 147.54 crore as compared to Rs 128.99 crore for the corresponding quarter last year. Its total income increased 13.07% at Rs 573.85 crore for the quarter under review from Rs 507.51 crore for the same quarter last year.

GlaxoSmithKline Pharmaceuticals, is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others.